AL-209

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameAL-209
Drug Alias NameAL-209ADNF-9SAL
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeurons stimulantsTubulin modulators
TargetsTubulin
Therapy Area/IndicationsCentral Nervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAllon Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAllon Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsCentral Nervous System Diseases

Other Information

ATC CodeN/A
Related LinksN/A